Effects of safflower seed extract supplementation on oxidation and cardiovascular risk markers in healthy human volunteers

British Journal of Nutrition

Volumn 101, Issue 4, 2009, Pages 568-575

  Koyama, Naoto ^a   Suzuki, Katsuya ^a   Furukawa, Yasushi ^a   Arisaka, Harumi ^a   Seki, Tetsuya ^a   Kuribayashi, Kanna ^a   Ishii, Koichi ^a   Sukegawa, Eiji ^a   Takahashi, Michio ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

8 Isoprostane; Human studies; Oxidized LDL; Safflower seed extract; Serotonin derivatives

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; C REACTIVE PROTEIN; GLUCOSE; LIPID; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SAFFLOWER OIL; SEROTONIN DERIVATIVE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANKLE BRACHIAL INDEX; ANTIBODY TITER; ANTIOXIDANT ACTIVITY; ARTERIAL STIFFNESS; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; JAPANESE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OXIDATIVE STRESS; PLANT SEED; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

CARTHAMUS TINCTORIUS; MUS;

EID: 67649443839     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/s0007114508025786     Document Type: Article

References (31)

1. O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA & Wiseman H (2001) Consumption of flavonoids in onions and black tea: Lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73, 1040-1044.
2. Mathur S, Devaraj S, Grundy SM & Jialal I (2002) Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr 132, 3663-3667.
3. Halliwell B, Rafter J & Jenner A (2005) Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: Direct or indirect effects? Antioxidant or not? Am J Clin Nutr 81, 268S-276S.
4. Herraiz T & Galisteo J (2004) Endogenous and dietary indoles: A class of antioxidants and radical scavengers in the ABTS assay. Free Radic Res 38, 323-331.
5. Fukutomi J, Fukuda A, Fukuda S, Hara M, Terada A & Yoshida M (2006) Scavenging activity of indole compounds against cisplatin-induced reactive oxygen species. Life Sci 80, 254-257.
6. Vincenzi FF & Hinds TR (1999) Stobadine: Bellwether of a broader view of drug actions. Life Sci 65, 1857-1864.
7. Hotta Y, Nagatsu A, Liu W, et al. (2002) Protective effects of antioxidative serotonin derivatives isolated from safflower against postischemic myocardial dysfunction. Mol Cell Biochem 238, 151-162.
8. Kim EO, Oh JH, Lee SK, Lee JY & Choi SW (2007) Antioxidant properties and quantification of phenolic compounds from safflower (Carthamus tinctorius L.) seeds. Food Sci Biotechnol 16, 71-77.
9. Koyama N, Kuribayashi K, Seki T, Kobayashi K, Furuhata Y, Suzuki K, Arisaka H, Nakano T, Amino Y & Ishii K (2006) Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem 54, 4970-4976.
10. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, Gutzki FM, Berger J, Frolich JC & Boger RH (2004) Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: A matched case-control study. Circulation 109, 843-848.
11. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F & Collen D (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98, 1487-1494.
12. Bui MN, Sack MN, Moutsatsos G, Lu DY, Katz P, McCown R, Breall JA & Rackley CE (1996) Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J 131, 663-667.
13. London GM & Cohn JN (2002) Prognostic application of arterial stiffness: task forces. Am J Hypertens 15, 754-758.
14. Yambe M, Tomiyama H, Hirayama Y, Gulniza Z, Takata Y, Koji Y, Motobe K & Yamashina A (2004) Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 27, 625-631.
15. Katsuda S, Koyama N, Suzuki K, Takahashi M, Takazawa K, Miyake M & Hazama A (2007) Safflower seed serotonin derivatives improve aortic pulse wave velocity and augmentation index in Kurosawa and Kusanagi-hypercholesterolemic rabbits. J Clin Biochem Nutr 41 Suppl., 118.
16. Singleton V, Orthofer R & Lamuela-Raventós RM (1999) Analysis of total polyphenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 299, 152-178.
17. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S & Yamamoto Y (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25, 359-364.
18. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S & Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464-478.
19. Ito Y, Nakachi K, Imai K, Hashimoto S, Watanabe Y, Inaba Y, Tamakoshi A & Yoshimura T (2005) Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol 15, Suppl. 1, S67-S73.
20. Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
21. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K & Cone JT (1986) Single vertical spin density gradient ultracentrifugation. Methods Enzymol 128, 181-209.
22. Tanno K, Ichiyanagi T, Ikeshiro Y & Hatano Y (2007) Pharmacokinetic behavior of serotonin derivatives, major antioxidants in safflower seed. J Clin Biochem Nutr 41, Suppl., 94.
23. Shirai Y, Ueno S, Ikeuchi K & Mihara R (2007) Pharmacokinetic study of N-feruloylserotonin and N-(p-coumaroyl)serotonin in rats. In 3rd International Conference on Polyphenols and Health (Program & Abstracts ICPH2007), p. 193. Japan: ICPH 2007 Organizing Committee.
24. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N & Hinohara S (2003) Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 166, 303-309.
25. Tsimikas S, Palinski W & Witztum JL (2001) Circulating auto-antibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 21, 95-100.
26. Cracowski JL, Durand T & Bessard G (2002) Isoprostanes as a biomarker of lipid peroxidation in humans: Physiology, pharmacology and clinical implications. Trends Pharmacol Sci 23, 360-366.
27. Palinski W & Witztum JL (2000) Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 247, 371-380.
28. Piga R, Naito Y, Kokura S, Handa O & Yoshikawa T (2007) Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 193, 328-334.
29. Kawashima S, Hayashi M, Takii T, Kimura H, Zhang HL, Nagatsu A, Sakakibara J, Murata K, Oomoto Y & Onozaki K (1998) Serotonin derivative, N-(p-coumaroyl) serotonin, inhibits the production of TNF-alpha, IL-1alpha, IL-1beta, and IL-6 by endotoxin-stimulated human blood monocytes. J Interferon Cytokine Res 18, 423-428.
30. Thurberg BL & Collins T (1998) The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 9, 387-396.
31. Yasuda H, Suzuki T, Zayasu K, Ishizuka S, Kubo H, Sasaki T, Nishimura H, Sekizawa K & Yamaya M (2005) Inflammatory and bronchospastic factors in asthma exacerbations caused by upper respiratory tract infections. Tohoku J Exp Med 207, 109-118.